receptor blocker which inhibits the binding cardura more drug interactions norepinephrine to alpha receptors in the autonomic nervous system. The primary effect of this blockage is relaxed vascular smooth muscle tone (vasodilation), cardura more drug interactions decreases peripheral vascular resistance, leading to decreased blood pressure.

?Therapeutic considerationsPregnancy cat. ?Legal status ? Prescription onlyRoutes oralDoxazosin mesylate, a quinazoline compound sold by Pfizer under the brand names Cardura® and Carduran® , is an alpha blocker used to treat high blood pressure and cardura more drug interactions prostatic hyperplasia.On February 22, 2005, the US FDA approved a sustained release form of doxazosin, to be marketed as Cardura® cardura more drug interactions is an alpha-1 adrenergic receptor blocker which inhibits the binding of norepinephrine to alpha receptors in the cardura more drug interactions nervous system. The primary effect cardura more drug interactions this blockage is relaxed vascular smooth muscle tone cardura more drug interactions which decreases peripheral vascular resistance, leading to decreased cardura more drug interactions pressure. DoxazosinFrom Wikipedia, the free cardura more drug interactions from Cardura)Jump to: navigation, searchDoxazosinSystematic (IUPAC) name[4-(4-amino-6,7-dimethoxy- quinazolin-2-yl) piperazin-1-yl]- (2,5-dioxabicyclo[4.4.0] deca-6,8,10-trien-4-yl) methanoneIdentifiersCAS number 74191-85-8ATC code C02CA04PubChem.

quinazolin-2-yl) piperazin-1-yl]- (2,5-dioxabicyclo[4.4.0] deca-6,8,10-trien-4-yl) methanoneIdentifiersCAS number.